|
|
|
|
LEADER |
00000nam a22000005i 4500 |
001 |
DEGRUYTERUP_9780226629216 |
003 |
DE-B1597 |
005 |
20220629043637.0 |
006 |
m|||||o||d|||||||| |
007 |
cr || |||||||| |
008 |
220629t20192019ilu fo d z eng d |
010 |
|
|
|a 2018051002
|
020 |
|
|
|a 9780226629216
|
035 |
|
|
|a (DE-B1597)535547
|
035 |
|
|
|a (OCoLC)1098034050
|
040 |
|
|
|a DE-B1597
|b eng
|c DE-B1597
|e rda
|
041 |
0 |
|
|a eng
|
044 |
|
|
|a ilu
|c US-IL
|
050 |
0 |
0 |
|a HD9673.S64
|b I74 2019
|
050 |
|
4 |
|a HD9673.S64
|b I74 2020
|
072 |
|
7 |
|a MED000000
|2 bisacsh
|
082 |
0 |
4 |
|a 338.76161510968
|2 23
|
100 |
1 |
|
|a Pollock, Anne,
|e author.
|4 aut
|4 http://id.loc.gov/vocabulary/relators/aut
|
245 |
1 |
0 |
|a Synthesizing Hope :
|b Matter, Knowledge, and Place in South African Drug Discovery /
|c Anne Pollock.
|
264 |
|
1 |
|a Chicago :
|b University of Chicago Press,
|c [2019]
|
264 |
|
4 |
|c ©2019
|
300 |
|
|
|a 1 online resource (208 p.) :
|b 7 halftones
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
0 |
|t Frontmatter --
|t CONTENTS --
|t INTRODUCTION --
|t ONE. Questioning the Bifurcations in Global Health Discourses --
|t TWO. In the Shadows of the Dynamite Factory --
|t THREE. Science for a Post- apartheid South Africa --
|t FOUR. "African Solutions for African Problems" --
|t FIVE. Im/materiality of Pharmaceutical Knowledge Making --
|t SIX. Hope in Flow --
|t EPILOGUE. The Afterlives of Hope --
|t Acknowledgments --
|t Notes --
|t Bibliography --
|t Index
|
506 |
0 |
|
|a restricted access
|u http://purl.org/coar/access_right/c_16ec
|f online access with authorization
|2 star
|
520 |
|
|
|a Synthesizing Hope opens up the material and social world of pharmaceuticals by focusing on an unexpected place: iThemba Pharmaceuticals. Founded in 2009 with a name taken from the Zulu word for hope, the small South African startup with an elite international scientific board was tasked with drug discovery for tuberculosis, HIV, and malaria. Anne Pollock uses this company as an entry point for exploring how the location of scientific knowledge production matters, not only for the raw materials, manufacture, licensing, and distribution of pharmaceuticals but also for the making of basic scientific knowledge. Consideration of this case exposes the limitations of global health frameworks that implicitly posit rich countries as the only sites of knowledge production. Analysis of iThemba identifies the problems inherent in global north/south divides at the same time as it highlights what is at stake in who makes knowledge and where. It also provides a concrete example for consideration of the contexts and practices of postcolonial science, its constraints, and its promise. Synthesizing Hope explores the many legacies that create conditions of possibility for South African drug discovery, especially the specific form of settler colonialism characterized by apartheid and resource extraction. Paying attention to the infrastructures and laboratory processes of drug discovery underscores the materiality of pharmaceuticals from the perspective of their makers, and tracing the intellectual and material infrastructures of South African drug discovery contributes new insights about larger social, political, and economic orders.
|
538 |
|
|
|a Mode of access: Internet via World Wide Web.
|
546 |
|
|
|a In English.
|
588 |
0 |
|
|a Description based on online resource; title from PDF title page (publisher's Web site, viewed 29. Jun 2022)
|
650 |
|
0 |
|a Drugs
|x Research
|z South Africa.
|
650 |
|
0 |
|a Pharmaceutical industry
|z South Africa.
|
650 |
|
7 |
|a MEDICAL / General.
|2 bisacsh
|
653 |
|
|
|a HIV.
|
653 |
|
|
|a South Africa.
|
653 |
|
|
|a drug discovery.
|
653 |
|
|
|a hope.
|
653 |
|
|
|a iThemba Pharmaceuticals.
|
653 |
|
|
|a infrastructures.
|
653 |
|
|
|a knowledge production.
|
653 |
|
|
|a pharmaceuticals.
|
653 |
|
|
|a science and technology studies.
|
653 |
|
|
|a synthetic chemistry.
|
773 |
0 |
8 |
|i Title is part of eBook package:
|d De Gruyter
|t EBOOK PACKAGE COMPLETE 2019 English
|z 9783110610765
|
773 |
0 |
8 |
|i Title is part of eBook package:
|d De Gruyter
|t EBOOK PACKAGE COMPLETE 2019
|z 9783110664232
|o ZDB-23-DGG
|
773 |
0 |
8 |
|i Title is part of eBook package:
|d De Gruyter
|t EBOOK PACKAGE Medicine and Life Sciences 2019 English
|z 9783110610536
|
773 |
0 |
8 |
|i Title is part of eBook package:
|d De Gruyter
|t EBOOK PACKAGE Medicine and Life Sciences 2019
|z 9783110606386
|o ZDB-23-DPM
|
773 |
0 |
8 |
|i Title is part of eBook package:
|d De Gruyter
|t University of Chicago Press Complete eBook-Package 2019
|z 9783110711943
|
776 |
0 |
|
|c print
|z 9780226629049
|
856 |
4 |
0 |
|u https://degruyter.uam.elogim.com/isbn/9780226629216
|z Texto completo
|
912 |
|
|
|a 978-3-11-061053-6 EBOOK PACKAGE Medicine and Life Sciences 2019 English
|b 2019
|
912 |
|
|
|a 978-3-11-061076-5 EBOOK PACKAGE COMPLETE 2019 English
|b 2019
|
912 |
|
|
|a 978-3-11-071194-3 University of Chicago Press Complete eBook-Package 2019
|b 2019
|
912 |
|
|
|a GBV-deGruyter-alles
|
912 |
|
|
|a ZDB-23-DGG
|b 2019
|
912 |
|
|
|a ZDB-23-DPM
|b 2019
|